Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Navigating the social media waters in healthcare

Regulations shouldn't prevent creative and engaging social media content

Shire Basingstoke

Shire files dry eye drug lifitegrast in Europe

Analysts predict Xiidra could become a $1bn product

Beacons for genuinely patient-centric marketing

How pharma marketing can respond to patient-centricity

- PMLiVE

Integration – beyond the buzzword

What it should be and how it can work in practice

- PMLiVE

Regeneron drops RSV drug

Suptavumab failed to prevent the infections in re-term infants

- PMLiVE

Merck CEO resigns from Trump post in Charlottesville protest

Frazier leaves the Manufacturing Council but J&J’s Gorksy remains for now

- PMLiVE

Toward an outcome

Disrupting the product-centred development cycle

- PMLiVE

Hacking Innovation

RB’s Lions Health event saw teams compete to protect children in China from air pollution

- PMLiVE

Time running out on new Stada takeover bid

Only 34% of shareholders have backed the deal so far

- PMLiVE

Being social – harnessing the power of social media

With around 2.8 billion people using social media today, it’s a powerful force – one that encompasses a broad spectrum of websites and applications. In addition to well-known websites like Facebook,...

Porterhouse Medical Group

- PMLiVE

Ionis must go it alone as GSK ditches polyneuropathy drug

Inotersen’s side effects prompts pharma giant to relinquish rights

- PMLiVE

NICE expands Merck KGaA’s Erbitux reach

Backs the medicines use for patients with SCCHN

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links